Sektor Samsung Biologics Co.,Ltd.

Aktien

A207940

KR7207940008

A207940

Pharmazeutika

Schlusskurs Korea S.E. 20.01.2025 % 5 Tage % 1. Jan.
1’015’000.00 KRW 0.00% Intraday Chart für Samsung Biologics Co.,Ltd. +1.50% +6.95%
Hauptkonkurrenten
Zu einer Liste hinzufügen
% % 5 Tage Veränderung - 1 Monat Veränderung - 3 Monate % 1. Jan. % 1 Jahr Veränd. 3 J. Veränd. 5 J. Veränd. 10 J. Kap. ($)
0.00%+1.50%+8.09%+1.50%+6.95%+31.82%+24.39%+131.74% - 50.21 Mrd.
-0.42%-2.35%-1.14%-9.04%-2.90%-5.39%+0.80%-9.90%+226.43%83.25 Mrd.
-0.11%-3.30%-4.46%+5.26%-4.73%+117.51%+100.90%+124.83%+164.18%36.13 Mrd.
+0.33%-1.20%-5.38%-23.46%-7.57%-43.08%-35.91%-50.79%-60.94%20.48 Mrd.
+1.37%+0.76%+3.78%+11.05%+4.94%+17.85%-3.09%-7.84%-6.39%13.86 Mrd.
+0.31%-0.18%+50.79%+64.69%+51.66%+88.15%+196.92%+398.09%+541.34%13.41 Mrd.
-0.98%-0.10%-10.35%-5.39%-2.92%+1.77%-37.45% - - 11.97 Mrd.
+1.47%-2.17%-5.80%-11.18%-5.03%-33.62%-26.26%-28.70%-35.07%11.73 Mrd.
+3.58%+6.52%+14.98%-17.59%+2.91%+321.30%+557.83%+1’694.37%+6’624.93%11.8 Mrd.
+1.81%+5.16%+8.75%+6.29%+6.49%+15.44%+84.50%+81.43%+303.34%10.34 Mrd.
+0.04%+1.55%-11.68%-23.52%-5.44%-49.74%-65.14%-38.34%+249.79%8.15 Mrd.
+0.81%-9.67%-10.70%-31.28%-14.48%-8.75%-25.12%-1.57% - 6.54 Mrd.
+2.94%-4.11%+22.94%+35.69%+24.42%-10.25%+231.46%+5.93% - 6.39 Mrd.
+0.15%+3.32%-5.26%-5.39%-5.26%-0.87%-5.39%-8.19%-46.34%6.19 Mrd.
-0.21%-1.95%-3.98%-11.64%-3.41%+0.23%-46.82%-71.98%-50.00%5.73 Mrd.
+7.01%+8.36%-0.10%-5.21%+1.22%-10.30%+1.29%+19.40%+137.63%5.25 Mrd.
+2.70%+10.65%+7.66%+2.31%+10.64%+2.96%+294.90%+5.50% - 4.46 Mrd.
-0.64%+11.40%+12.49%-4.12%+8.72%+42.65%+176.31%+86.16% - 4.47 Mrd.
-0.13%+1.16%-11.56%-3.02%-6.47%-17.23%-43.17%-42.27%+35.27%3.95 Mrd.
+0.62%-0.67%-8.52%+3.78%-5.48%+206.43%+1’017.93%+265.09%+47.36%3.79 Mrd.
Durchschnitt +1.07%+2.30%+2.53%-1.01%+2.71%+33.34%+119.94%+134.37%+580.82% 15.9 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung +0.43%+0.35%+2.47%-1.84%+1.77%+30.97%+62.16%+116.25%+487.47%
Biopharmazeutika
  1. Börse
  2. Aktien
  3. A207940 Aktie
  4. Sektor Samsung Biologics Co.,Ltd.